Disc Medicine Inc.
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associ… Read more
Disc Medicine Inc. (IRON) - Total Liabilities
Latest total liabilities as of September 2025: $57.07 Million USD
Based on the latest financial reports, Disc Medicine Inc. (IRON) has total liabilities worth $57.07 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Disc Medicine Inc. - Total Liabilities Trend (2020–2024)
This chart illustrates how Disc Medicine Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Disc Medicine Inc. Competitors by Total Liabilities
The table below lists competitors of Disc Medicine Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Reliance Worldwide Corporation Limited
PINK:RLLWF
|
USA | $820.88 Million |
|
Joulwatt Technology Co. Ltd. A
SHG:688141
|
China | CN¥3.01 Billion |
|
Photronics Inc
NASDAQ:PLAB
|
USA | $251.50 Million |
|
JB Chemicals & Pharmaceuticals Limited
NSE:JBCHEPHARM
|
India | ₹9.07 Billion |
|
Changzhou Fusion New Material Co. Ltd. A
SHG:688503
|
China | CN¥4.71 Billion |
|
Dynex Capital Inc
NYSE:DX
|
USA | $12.20 Billion |
|
Aecc Aero Engine Control Co Ltd
SHE:000738
|
China | CN¥3.17 Billion |
|
BTS Group Holdings Public Company Limited
PINK:BTGWF
|
USA | $217.99 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Disc Medicine Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 23.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Disc Medicine Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Disc Medicine Inc. (2020–2024)
The table below shows the annual total liabilities of Disc Medicine Inc. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $53.19 Million | +132.51% |
| 2023-12-31 | $22.88 Million | -3.09% |
| 2022-12-31 | $23.61 Million | -84.93% |
| 2021-12-31 | $156.61 Million | +418.93% |
| 2020-12-31 | $30.18 Million | -- |